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as the procedure of choice in children with aortic valve
disease and complex LVOTO.
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Impact of optimal medical therapy (OMT), versus
optimal medical therapy plus revascularizations
(OMTR) on allcause mortality, in patients with
IHD
Iyad Farah, Tara Conboy, M. Bassam Bdeir
Background: Currently, there is no significant differ-
ence between OMT versus OMTR on all-cause mortality
in patients with IHD. There is no data in this region.
Objectives: Evaluate the impact of OMT versus
OMTR on primary end point of allcause mortality in
patients with IHD.
Method: Data was collected, retrospectively, from
the electronic database for all patients with IHD
(n = 2,692) attending Cardiovascular Disease Manage-
ment Program (CVDMP), KAMC-Riyadh, between April
2000 and October 2011. Patients with no follow-up visits
(n = 59), or had non obstructive CAD (n = 280) were
excluded. OMT is an integral component of routine care
within CVDMP. Data was analyzed using SPSS.
Results: Mean age was 60 ± 10 years, 22% were
female, and average follow-up was 40 ± 33 months. Base-
line characteristics were similar for both groups with
exception of LVEF which was 38% versus 46% (p < 0.001),
and documented heart failure (HF) 60% versus 31%
(p < 0.001), respectively in OMT and OMTR. Of the
enrolled patients (n = 2353), 86% (n = 2031) underwent
revascularization, while 14% (n = 322) remained on OMT
for the following reasons; 18% (n = 59) refused interven-
tion and 82% (n = 263) were declined intervention by the
treating team. All-cause mortality was 3.3% (n = 87) in
the total population; 2.2% (45/2031) in the OMTR group
versus 11% (35/322) in the OMT group (P < 0.0001).
Conclusion: Mortality was higher in OMT group,
which had a higher prevalence of HF and lower baseline
LVEF.
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IV Paracetamol as a sole agent for postoperative
pain relief in adult cardiac surgical patients after
median sternotomy
Jamshid Ali Mullah, Khaled Farouk, Mutasim
Hammad
1&3 Consultant Cardiac Anesthesia, 2 Consultant CCM,
PSCCQ, Saudi Arabia
Introduction: Various pain control strategies for pain
relief of cardiac surgical patients after median sternotomy
were tried include central neuraxial blockade or selective
nerve blocks, anddrugs such as opioids, andnon-steroidal
anti-inflammatory drugs (NSAIDS). Paracetamol (Perfal-
gan, Bristol Meyers Squibb) is available in IV formulation
and is being used inmany centers as an adjunct to analge-
sia regimen. In our practice, we have found that IV para-
cetamol stared at regular intervals after shifting the
patient to cardiac surgical ICU(CSICU), helps in signifi-
cantly reducing the analgesic requirement consequently
patients become less sedated after cardiac surgery.
Methods: After ethics committee approval, and
informed patient consent, we did a prospective cohort
study of 52 adult cardiac surgical receiving IV paracetamol
as the primary pain control agent. A standard anesthesia
andanalgesia techniquewasused for all thepatients. Post-
operatively IV fentanyl infusion was continued at 1 mcg/
kg/h till extubation. IV paracetamol was started 30 min
before extubation given 1 g (over 30 min) IV and continued
6 h till next 72 h or till chest tube removal. Pain control was
assessed by visual analogue scale (VAS) and target VAS
value of 3 or less than three was considered adequate.
VAS was assessed at extubation, at 3, 6, 12, 24, 36 and
48 h after extubation. The regimen was considered suc-
cessful if only two or less than two doses of IV fentanyl
and/or less than 4 doses of oral tramadol were required
to supplement IV paracetamol postoperatively.
Results: The patient age ranged from 24 to 78 years,
8 of them were female, CABG was performed in 14
patients, AVR in 8 patients, CABG plus MVR in 6
patients, CABG plus AVR in 10 patients, MVR plus
RFA in 6 patients, ASD closure in 4 patients and pulmon-
ary valve implantation in 2 patient. We found that para-
cetamol was successful as the sole analgesic agent in 38
patients (73%), in 10 patients (19.2%) IV paracetamol
was primary regimen (with fentanyl/tramadol as adjunct)
and in 4 patients (7.6%) patients IV paracetamol regimen
was unsuccessful in pain relief.
Conclusion: IV Paracatamol may be used as a sole
agent for pain relief with successful results after median
sternotomy in selected patients in which opioids, NSAIDS
or regional blocks are not indicated or produce undesirable
side effects. The results need to be reproduced in a larger
group of patients and after determining equipotent doses
of opiods, case control studies should be done to evaluate
the effects of IV paracetamol after median sternotomy.
http://dx.doi:10.1016/j.jsha.2013.03.090
Clinical and prognostic comparison between Mid-
dle-East and Indian subcontinent patients follow-
ing acute coronary syndrome
Kadhim Sulaiman, Prashanth Panduranga,
Ibrahim Alzakwani, Khalid Al-Habib,
Ahmed Hersi, Jassim Al Suwaidi
Background: Data comparing acute coronary syn-
drome (ACS) patients from the Middle East with those
from the Indian subcontinent is scarce. The aim of this
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